About this market
The growing demand for blood and blood components will be one of the key factors expected to trigger the hematology analyzers and reagents market growth in the forthcoming years. Blood component therapy allows patients for benefitting from one pint of whole blood. Blood and its components are required when the body fails in producing enough blood components for meeting the body’s requirements. As a result, the rising demand for blood and blood components for treating medical conditions is further boosting the demand for hematology analyzers for measuring blood constituents. analysts have predicted that the hematology analyzers and reagents market will register a CAGR of nearly 6% by 2023.
Market Overview
The rising number of organ transplant procedures
One of the growth drivers of the global hematology analyzers and reagents market is the rising number of organ transplant procedures. During transplantation, red blood cells transfusion is required to support the functioning of the organs which necessitates the need for hematology analyzers.
Lack of adoption of automated hematology analyzer solutions by smaller laboratories
One of the challenges in the growth of global hematology analyzers and reagents market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories. The high cost of the initial set up and instrumentation and the subsequent cost of maintenance are likely to affect the demand for hematology analyzers.
For the detailed list of factors that will drive and challenge the growth of the hematology analyzers and reagents market during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately concentrated and with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.